ANTI-PARKINSON DRUGS

Akenpark Tablets – 2 mg Biperiden

Active ingredient: Biperiden hydrochloride Composition 1 tablet contains 2 mg of Biperiden hydrochlonde Mode of action Akenpark is a centrally-acting anticholinergic which owes its therapeutic action in parkinsonian syndrome and drug-induced extrapyramidal symptoms to competitive binding to muscarinic receptors especially the M1 receptors. Indications and usage As an adjunct in the therapy of all forms …

Akenpark Tablets – 2 mg Biperiden Read More »

Biperiden 2 mg Tablets

Active ingredient: Biperiden hydrochloride Composition 1 tablet contains 2 mg of Biperiden hydrochlonde Mode of action Biperiden is a centrally-acting anticholinergic which owes its therapeutic action in parkinsonian syndrome and drug-induced extrapyramidal symptoms to competitive binding to muscarinic receptors especially the M1 receptors. Indications and usage As an adjunct in the therapy of all forms …

Biperiden 2 mg Tablets Read More »

Akineton Tablets – 2 mg Biperiden

Active ingredient: Biperiden hydrochloride Composition 1 tablet contains 2 mg of Biperiden hydrochlonde Mode of action Akineton is a centrally-acting anticholinergic which owes its therapeutic action in parkinsonian syndrome and drug-induced extrapyramidal symptoms to competitive binding to muscarinic receptors especially the M1 receptors. Indications and usage As an adjunct in the therapy of all forms …

Akineton Tablets – 2 mg Biperiden Read More »

Achtenon Tablets – 2 mg Biperiden

Active ingredient: Biperiden hydrochloride Composition 1 tablet contains 2 mg of Biperiden hydrochlonde Mode of action Achtenon is a centrally-acting anticholinergic which owes its therapeutic action in parkinsonian syndrome and drug-induced extrapyramidal symptoms to competitive binding to muscarinic receptors especially the M1 receptors. Indications and usage As an adjunct in the therapy of all forms …

Achtenon Tablets – 2 mg Biperiden Read More »

Parkintreat 1 mg tablets for Parkinson’s disease

Parkintreat is indicated for the treatment of idiopathic Parkinson’s disease (PD) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations. Parkintreat is used alone or in combination with another medication to treat the symptoms of Parkinson’s disease (a slowly progressing disease of the nervous system causing a fixed face without …

Parkintreat 1 mg tablets for Parkinson’s disease Read More »